{"schema_version":"secwatch.filing_event.v1","accession":"0001326190-24-000036","form_type":"8-K","ticker":"ALT","cik":"0001326190","company_name":"Altimmune, Inc.","filed_at":"2024-08-15T23:59:59+00:00","discovered_at":"2026-05-14T18:03:12.610417+00:00","generated_at":"2026-05-31T08:58:33.490239+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"confidence":"high","headline":"Altimmune director David Drutz will not stand for re-election at 2024 annual meeting","bullets":["David J. Drutz, M.D. notified the Board that he will not stand for re-election at the 2024 Annual Meeting of Shareholders.","Drutz will continue as a director until the date of the Annual Meeting; his decision is not due to any disagreement with the company.","The Board thanked Dr. Drutz for his service; no replacement has been announced as he will not stand for re-election."],"urls":{"canonical":"https://secwatch.observer/filing/0001326190-24-000036","json":"https://secwatch.observer/filing/0001326190-24-000036.json","markdown":"https://secwatch.observer/filing/0001326190-24-000036.md","text":"https://secwatch.observer/filing/0001326190-24-000036.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1326190/000132619024000036/0001326190-24-000036-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1326190/000132619024000036/alt-20240813x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T08:58:33.490239+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"5de5ab87e9","claim":"David J. Drutz departed as Director at Altimmune, Inc..","evidence_excerpt":"On August 13, 2024, David J. Drutz, M.D. notified the Board of Directors (the “Board”) of Altimmune, Inc. (the “Company”) that he has decided not to stand for re-election to the Board at the Company’s 2024 Annual Meeting of Shareholders (the “Annual Meeting”).","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1326190/000132619024000036/0001326190-24-000036-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"decided not to stand for re-election"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}